Western Pacific Wealth Management, LP Crispr Therapeutics Ag Transaction History
Western Pacific Wealth Management, LP
- $105 Million
- Q1 2025
A detailed history of Western Pacific Wealth Management, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 1,000 shares of CRSP stock, worth $52,170. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$52,170
Previous $39,000
12.82%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
480Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$530 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$317 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$198 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$145 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$133 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.07B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....